Though MT has resigned, however he is wholeheartedly supporting FDA designation of monepantel (MPL) as ODD. He is not hesitant to say this is a blockbuster drug to MND/ALS and hardly one study away from approval to commercialise in AU, Europe US and many countries. Many of us still believe he will return to the board (but I doubt that)
PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial, page-202
-
- There are more pages in this discussion • 777 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
16.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $80.22M | |||
| Open | High | Low | Value | Volume |
| 16.5¢ | 17.0¢ | 16.0¢ | $63.88K | 389.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 113677 | 16.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 16.5¢ | 4074 | 2 |
View Market Depth
| Last trade - 10.46am 08/08/2024 (20 minute delay) ? |
| PAA (ASX) Chart |